|
Volumn 131, Issue 5, 2002, Pages 534-540
|
Enteral fluconazole is well absorbed in critically ill surgical patients
a,b a,b a,b a,b a,b a,b,c
c
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
FLUCONAZOLE;
PLACEBO;
TRIAZOLE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA PARAPSILOSIS;
CANDIDA TROPICALIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRITICAL ILLNESS;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
FEMALE;
HUMAN;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
MYCOSIS;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURGICAL PATIENT;
|
EID: 0036255691
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1067/msy.2002.123803 Document Type: Article |
Times cited : (14)
|
References (13)
|